CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva ...

Built on Purpose, Growing with Heart CINCINNATI, OH / ACCESS Newswire / June 3, 2025 / In just one year, AcutePet Urgent Care ...

Sanofi announced today that the U.S. FDA has granted orphan drug designation to rilzabrutinib for the treatment of sickle ...

New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / June 3, 2025 / Hemogenyx Pharmaceuticals plc is pleased to ...

MUNICH, GERMANY AND LONDON, UK / ACCESS Newswire / June 3, 2025 / Infineon Technologies AG, a world leader in semiconductor solutions, today announced a strategic partnership with The Healthcare ...

One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes This data supports a strong safety profile for the VCFix® Spinal System for the ...

Longevity Method, a leader in advanced health and wellness solutions, announces the launch of Live Longer - NMN+, a revolutionary NMN supplement designed to enhance cellular health and combat ...

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity ...

Notice to convene extraordinary GENERAL MEETING REGARDING EXTRAORDINARY DIVIDENDGUBRA A/SCVR NO. 30 51 40 41To the shareholders of Gubra A/S (CVR no. 30 51 40 41), notice is hereby given to convene an ...

The global sales of rare neurological disease treatment is estimated to be worth USD 19.95 billion in 2025 and anticipated to reach a value of USD 40.67 billion by 2035. Sales are projected to rise at ...

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach ...